Health Condition 1: L818- Other specified disorders of pigmentation
Conditions
Interventions
Intervention1: Microneedling with with tranexamic acid
in the treatment of melasma: For patients with melasma
microneedling with tranexamic acid given at baseline
then every 2 weeks for a maximum of
Sponsors
Vinayaka Missions Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinical diagnosis of melasma Patients who are willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients allergic to Tranaxemic acid Patients with predisposition to keloids Pregnant and lactating mothers Patients with history of bleeding disorders use of oral anticoagulant drugs Patients under oral contraceptive pills hormonal replacement therapy at the time of or during the past 12 months of study Patients with a history of treatment for melasma in the past 6 weeks in any form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the clinical response by mMASI and PtGA score to microneedling with tranexamic acid and microinjections with tranexamic acid in treatment of melasma Timepoint: every 2 weeks for 3 months, and at the end of 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment side effectsTimepoint: Every 4 weeks for 3 months and at the end of 6 months | — |
Countries
India
Contacts
Public ContactDr V JAYAMALIGA
VINAYAKA MISSIONS MEDICAL COLLEGE KARAIKAL
Outcome results
None listed